Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Wire Burundi.
July 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 | 31 |
August 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | ||||
| 4 | 5 | 6 | 7 | 8 | 9 | 10 |
| 11 | 12 | 13 | 14 | 15 | 16 | 17 |
| 18 | 19 | 20 | 21 | 22 | 23 | 24 |
| 25 | 26 | 27 | 28 | 29 | 30 | 31 |
September 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 |
| 8 | 9 | 10 | 11 | 12 | 13 | 14 |
| 15 | 16 | 17 | 18 | 19 | 20 | 21 |
| 22 | 23 | 24 | 25 | 26 | 27 | 28 |
| 29 | 30 |
Press releases published on August 12, 2025
NetraMark Appoints Jan Sedway as Senior Vice President of Clinical Science to Accelerate Growth and Market Leadership
GlobeNewswire
·
August 12, 2025
TORONTO, Aug. 12, 2025 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the "Company" or "NetraMark") (CSE: AIAI) (OTCQB: AINMF) (Frankfurt:PF0) a premier artificial intelligence (AI) company transforming clinical trials today announced the appointment of Jan …
Branded Legacy, Inc. Finalizes Transformative Acquisition of Bio Legacy Evaluative Group (f/k/a Menlo Health), Unlocking Explosive Growth Potential in Biotech and Drug Delivery
GlobeNewswire
·
August 12, 2025
VANCOUVER, British Columbia, Aug. 12, 2025 (GLOBE NEWSWIRE) -- via IBN -- Branded Legacy, Inc. (OTC: BLEG), a dynamic diversified holdings company at the forefront of health and wellness innovation, is excited to announce the completion of its game- …
Fifty1 Labs, Inc. and BioSpark AI Unlock 2,000+ Real-World Treatment Pathways to Accelerate Functional Medicine Innovation
GlobeNewswire
·
August 12, 2025
VANCOUVER, British Columbia and PALO ALTO, Calif., Aug. 12, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty1 AI Labs, a subsidiary of Fifty 1 Labs, Inc. (OTC: FITY), together with its commercial partner BioSpark AI Technologies Inc., is announcing a major …
AVITA Medical Successfully Completes Australian Equity Raise
GlobeNewswire
·
August 12, 2025
Private placement of approximately 17.2 million new CHESS Depositary Interests (“New CDIs”) quoted on the Australian Securities Exchange (ASX) Issue price of A$1.32 per New CDI, raising approximately US$15 million (~A$23 million), with participation from …
Biotricity to Host Fiscal 2026 First Quarter Financial Results and Business Update Call on August 14th
GlobeNewswire
·
August 12, 2025
Company to announce continued Revenue Growth, Improvements in Margins, Operational Efficiency, and a shift to positive EBITDA REDWOOD CITY, Calif., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), an innovative Technology-as-a-Service (TaaS) …
Orchestra BioMed Reports Second Quarter 2025 Financial Results and Highlights Recent Business Updates
GlobeNewswire
·
August 12, 2025
Secured over $111 million in proceeds and committed capital following completion of strategic transactions and concurrent public and private equity offerings, led by over $71 million in committed capital from Medtronic and Ligand Achieved multiple FDA …
Smart Sensing Revolution: Global Market to Reach $323.3 Billion by 2030
GlobeNewswire
·
August 12, 2025
Boston, Aug. 12, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, the “Sensors: Technologies and Global Markets" is projected to increase from $212.5 billion in 2025 to $323.3 billion by 2030, at a compound annual growth rate (CAGR …
Taysha Gene Therapies Reports Second Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
August 12, 2025
Commenced site activation for REVEAL pivotal trial in accordance with previously aligned upon key design elements, following receipt of No Objection Letter (NOL) from Health Canada and feedback from the FDA; patient enrollment anticipated to begin in Q4 …
Silexion Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
August 12, 2025
GRAND CAYMAN, Cayman Islands, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) ("Silexion" or the "Company"), a clinical-stage biotechnology company developing RNA interference (RNAi) therapies for KRAS-driven cancers, today …
57 Confluent Health Physical and Occupational Therapists Receive Board-Certified Clinical Specialist Credential
GlobeNewswire
·
August 12, 2025
LOUISVILLE, Ky., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Fifty-seven Physical and Occupational Therapists from Confluent Health’s Partner Brands have achieved nationally recognized board certifications, a prestigious milestone that places them among the top …
SimpleTherapy Ranks No. 1234 on the 2025 Inc. 5000 List of America’s Fastest-Growing Private Companies
GlobeNewswire
·
August 12, 2025
FRESNO, Calif., Aug. 12, 2025 (GLOBE NEWSWIRE) -- SimpleTherapy, a leading omnichannel care provider of musculoskeletal (MSK) and behavioral health care solutions, is proud to announce its inclusion in the 2025 Inc. 5000 list, a prestigious ranking of the …
Autoinjectors Market Set to Surpass USD 3.02 Billion by 2030 as Demand for Advanced Drug Delivery Systems Accelerates | MarketsandMarkets™.
GlobeNewswire
·
August 12, 2025
Delray Beach, FL, Aug. 12, 2025 (GLOBE NEWSWIRE) -- The global autoinjectors market, valued at US$1.08 billion in 2023, stood at US$1.40 billion in 2024 and is projected to advance at a resilient CAGR of 13.6% from 2024 to 2030, culminating in a forecasted …
Elicio Therapeutics Announces Publication of ELI-002 Updated AMPLIFY-201 Phase 1 Follow-up Data in Nature Medicine for Minimal Residual Disease (“MRD”) Positive, Adjuvant-Stage Patients
GlobeNewswire
·
August 12, 2025
At extended median follow-up of 19.7 months, median overall survival (“OS”) increased from 16.33 to 28.94 months Clinical efficacy correlated with the magnitude of T cell responses specific to mutant-KRAS (“mKRAS”) induced by ELI-002 77% reduction in the …
PolyPid Appoints Dr. Nurit Tweezer-Zaks as Chief Medical Officer
GlobeNewswire
·
August 12, 2025
PETACH TIKVA, Israel, Aug. 12, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced the appointment of Dr. Nurit Tweezer-Zaks, M.D., M.B.A., …
Counslr Launches in Schools Across the Country to Increase Mental Health Care Access
GlobeNewswire
·
August 12, 2025
NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Counslr, a leading mental health and wellness platform, announced today that it has expanded its footprint, partnering with many school districts across the country in anticipation of the 2025-26 school year as …
Aprea Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Clinical Update
GlobeNewswire
·
August 12, 2025
Early evidence of disease control was observed in the ongoing Phase 1 ACESOT-1051 trial, with three patients achieving stable disease in the 70 mg and 100 mg cohorts treated with the WEE1 inhibitor, APR-1051 $16.5 million in cash and cash equivalents as of …
Cerevance to Participate in Piper Sandler Virtual CNS Symposium
GlobeNewswire
·
August 12, 2025
BOSTON, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Cerevance, a clinical-stage biopharmaceutical company advancing multiple cell type-specific therapies for the treatment of neurodegenerative diseases and obesity, today announced participation at the Piper Sandler …
Monopar Therapeutics Reports Second Quarter 2025 Financial Results and Recent Developments
GlobeNewswire
·
August 12, 2025
WILMETTE, Ill., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical‐stage biopharmaceutical company focused on developing innovative treatments for patients with unmet medical needs, today …
Aardvark Therapeutics Announces ARD-201 Preclinical Obesity Data Showing Significant Weight Loss as a Monotherapy, Enhancement of GLP-1RA Therapy in Combination, and Effective Maintenance Following Discontinuation of GLP-1RA Therapy
GlobeNewswire
·
August 12, 2025
In a gold-standard model of obesity, treatment with ARD-201 resulted in approximately 19% body weight reduction after 30 days of treatment. ARD-201 was also associated with attenuated weight regain after discontinuation of tirzepatide. In combination with …
electroCore Names Kelly Benning, Accomplished Healthcare Executive, as SVP of Truvaga
GlobeNewswire
·
August 12, 2025
ROCKAWAY, N.J., Aug. 12, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that Kelly Benning has been hired as the Senior Vice President of Truvaga, effective July 21 …